"Raclopride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A substituted benzamide that has antipsychotic properties. It is a dopamine D2 receptor (see RECEPTORS, DOPAMINE D2) antagonist.
Descriptor ID |
D020891
|
MeSH Number(s) |
D02.065.277.761 D02.241.223.100.100.761 D02.241.223.100.200.937 D02.455.426.559.389.127.085.761 D02.455.426.559.389.127.250.937
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Raclopride".
Below are MeSH descriptors whose meaning is more specific than "Raclopride".
This graph shows the total number of publications written about "Raclopride" by people in this website by year, and whether "Raclopride" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Raclopride" by people in Profiles.
-
Kelp A, Koeppen AH, Petrasch-Parwez E, Calaminus C, Bauer C, Portal E, Yu-Taeger L, Pichler B, Bauer P, Riess O, Nguyen HP. A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers. J Neurosci. 2013 May 22; 33(21):9068-81.
-
Guilarte TR, Chen MK, McGlothan JL, Verina T, Wong DF, Zhou Y, Alexander M, Rohde CA, Syversen T, Decamp E, Koser AJ, Fritz S, Gonczi H, Anderson DW, Schneider JS. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp Neurol. 2006 Dec; 202(2):381-90.